Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:49 UTC |
---|
Update Date | 2022-03-07 02:51:41 UTC |
---|
HMDB ID | HMDB0014629 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Nabilone |
---|
Description | Nabilone is a synthetic cannabinoid with therapeutic use as an antiemetic and as an adjunct analgesic for neuropathic pain. It is a synthetic cannabinoid, which mimics the main ingredient of marijuana (THC) but it has more predictable side effects and causes no or minimal euphoria. Nabilone is not derived from the cannabis plant as is dronabinol. In Canada, the United States, the United Kingdom and Mexico, nabilone is marketed as Cesamet. It was approved in 1985 by the United States FDA for treatment of chemotherapy-induced nausea and vomiting that has not responded to conventional antiemetics. Though it was approved by the FDA in 1985, the drug only began marketing in the United States in 2006. It is also approved for use in treatment of anorexia and weight loss in patients with AIDS. Although it doesn't have the official indication (except in Mexico), nabilone is widely used as an adjunct therapy for chronic pain management. Numerous trials and case studies have demonstrate various benefits for condition such as fibromyalgia and multiple scerosis. Nabilone is a racemate consisting of the (S,S) and the (R,R) isomers ('trans'). |
---|
Structure | [H][C@@]12CC(=O)CC[C@@]1([H])C(C)(C)OC1=CC(=CC(O)=C21)C(C)(C)CCCCCC InChI=1S/C24H36O3/c1-6-7-8-9-12-23(2,3)16-13-20(26)22-18-15-17(25)10-11-19(18)24(4,5)27-21(22)14-16/h13-14,18-19,26H,6-12,15H2,1-5H3/t18-,19-/m1/s1 |
---|
Synonyms | Value | Source |
---|
Cesamet | Kegg | Nabilone, (6ar-trans)-isomer | HMDB | Nabilone, (cis-(+-))-isomer | HMDB | Nabilone, (6as-trans)-isomer | HMDB | Nabilone, (trans-(+-))-isomer | HMDB | Lilly brand OF nabilone | HMDB |
|
---|
Chemical Formula | C24H36O3 |
---|
Average Molecular Weight | 372.5408 |
---|
Monoisotopic Molecular Weight | 372.266445018 |
---|
IUPAC Name | (6aR,10aR)-1-hydroxy-6,6-dimethyl-3-(2-methyloctan-2-yl)-6H,6aH,7H,8H,9H,10H,10aH-benzo[c]isochromen-9-one |
---|
Traditional Name | nabilone |
---|
CAS Registry Number | 51022-71-0 |
---|
SMILES | [H][C@@]12CC(=O)CC[C@@]1([H])C(C)(C)OC1=CC(=CC(O)=C21)C(C)(C)CCCCCC |
---|
InChI Identifier | InChI=1S/C24H36O3/c1-6-7-8-9-12-23(2,3)16-13-20(26)22-18-15-17(25)10-11-19(18)24(4,5)27-21(22)14-16/h13-14,18-19,26H,6-12,15H2,1-5H3/t18-,19-/m1/s1 |
---|
InChI Key | GECBBEABIDMGGL-RTBURBONSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as naphthopyranones. Naphthopyranones are compounds containing a naphthopyran skeleton where a ring carbon bears a carboxylic acid group. Naphthtopyran is made up of the pyran ring fused to a naphthalene ring system. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Naphthopyrans |
---|
Sub Class | Naphthopyranones |
---|
Direct Parent | Naphthopyranones |
---|
Alternative Parents | |
---|
Substituents | - Naphthopyranone
- 2,2-dimethyl-1-benzopyran
- Chromane
- Benzopyran
- 1-benzopyran
- 1-hydroxy-4-unsubstituted benzenoid
- 1-hydroxy-2-unsubstituted benzenoid
- Alkyl aryl ether
- Benzenoid
- Ketone
- Cyclic ketone
- Ether
- Oxacycle
- Organic oxygen compound
- Carbonyl group
- Hydrocarbon derivative
- Organic oxide
- Organooxygen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.00049 g/L | Not Available | LogP | 6.8 | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Nabilone,1TMS,isomer #1 | CCCCCCC(C)(C)C1=CC2=C(C(O[Si](C)(C)C)=C1)[C@@H]1CC(=O)CC[C@H]1C(C)(C)O2 | 2678.4 | Semi standard non polar | 33892256 | Nabilone,1TMS,isomer #2 | CCCCCCC(C)(C)C1=CC(O)=C2C(=C1)OC(C)(C)[C@@H]1CC=C(O[Si](C)(C)C)C[C@@H]21 | 2689.9 | Semi standard non polar | 33892256 | Nabilone,1TMS,isomer #3 | CCCCCCC(C)(C)C1=CC(O)=C2C(=C1)OC(C)(C)[C@@H]1CCC(O[Si](C)(C)C)=C[C@@H]21 | 2683.8 | Semi standard non polar | 33892256 | Nabilone,2TMS,isomer #1 | CCCCCCC(C)(C)C1=CC2=C(C(O[Si](C)(C)C)=C1)[C@@H]1CC(O[Si](C)(C)C)=CC[C@H]1C(C)(C)O2 | 2715.9 | Semi standard non polar | 33892256 | Nabilone,2TMS,isomer #1 | CCCCCCC(C)(C)C1=CC2=C(C(O[Si](C)(C)C)=C1)[C@@H]1CC(O[Si](C)(C)C)=CC[C@H]1C(C)(C)O2 | 2826.0 | Standard non polar | 33892256 | Nabilone,2TMS,isomer #1 | CCCCCCC(C)(C)C1=CC2=C(C(O[Si](C)(C)C)=C1)[C@@H]1CC(O[Si](C)(C)C)=CC[C@H]1C(C)(C)O2 | 3100.8 | Standard polar | 33892256 | Nabilone,2TMS,isomer #2 | CCCCCCC(C)(C)C1=CC2=C(C(O[Si](C)(C)C)=C1)[C@@H]1C=C(O[Si](C)(C)C)CC[C@H]1C(C)(C)O2 | 2739.3 | Semi standard non polar | 33892256 | Nabilone,2TMS,isomer #2 | CCCCCCC(C)(C)C1=CC2=C(C(O[Si](C)(C)C)=C1)[C@@H]1C=C(O[Si](C)(C)C)CC[C@H]1C(C)(C)O2 | 2830.8 | Standard non polar | 33892256 | Nabilone,2TMS,isomer #2 | CCCCCCC(C)(C)C1=CC2=C(C(O[Si](C)(C)C)=C1)[C@@H]1C=C(O[Si](C)(C)C)CC[C@H]1C(C)(C)O2 | 3112.1 | Standard polar | 33892256 | Nabilone,1TBDMS,isomer #1 | CCCCCCC(C)(C)C1=CC2=C(C(O[Si](C)(C)C(C)(C)C)=C1)[C@@H]1CC(=O)CC[C@H]1C(C)(C)O2 | 2891.6 | Semi standard non polar | 33892256 | Nabilone,1TBDMS,isomer #2 | CCCCCCC(C)(C)C1=CC(O)=C2C(=C1)OC(C)(C)[C@@H]1CC=C(O[Si](C)(C)C(C)(C)C)C[C@@H]21 | 2934.3 | Semi standard non polar | 33892256 | Nabilone,1TBDMS,isomer #3 | CCCCCCC(C)(C)C1=CC(O)=C2C(=C1)OC(C)(C)[C@@H]1CCC(O[Si](C)(C)C(C)(C)C)=C[C@@H]21 | 2913.7 | Semi standard non polar | 33892256 | Nabilone,2TBDMS,isomer #1 | CCCCCCC(C)(C)C1=CC2=C(C(O[Si](C)(C)C(C)(C)C)=C1)[C@@H]1CC(O[Si](C)(C)C(C)(C)C)=CC[C@H]1C(C)(C)O2 | 3177.5 | Semi standard non polar | 33892256 | Nabilone,2TBDMS,isomer #1 | CCCCCCC(C)(C)C1=CC2=C(C(O[Si](C)(C)C(C)(C)C)=C1)[C@@H]1CC(O[Si](C)(C)C(C)(C)C)=CC[C@H]1C(C)(C)O2 | 3185.3 | Standard non polar | 33892256 | Nabilone,2TBDMS,isomer #1 | CCCCCCC(C)(C)C1=CC2=C(C(O[Si](C)(C)C(C)(C)C)=C1)[C@@H]1CC(O[Si](C)(C)C(C)(C)C)=CC[C@H]1C(C)(C)O2 | 3302.4 | Standard polar | 33892256 | Nabilone,2TBDMS,isomer #2 | CCCCCCC(C)(C)C1=CC2=C(C(O[Si](C)(C)C(C)(C)C)=C1)[C@@H]1C=C(O[Si](C)(C)C(C)(C)C)CC[C@H]1C(C)(C)O2 | 3181.8 | Semi standard non polar | 33892256 | Nabilone,2TBDMS,isomer #2 | CCCCCCC(C)(C)C1=CC2=C(C(O[Si](C)(C)C(C)(C)C)=C1)[C@@H]1C=C(O[Si](C)(C)C(C)(C)C)CC[C@H]1C(C)(C)O2 | 3202.4 | Standard non polar | 33892256 | Nabilone,2TBDMS,isomer #2 | CCCCCCC(C)(C)C1=CC2=C(C(O[Si](C)(C)C(C)(C)C)=C1)[C@@H]1C=C(O[Si](C)(C)C(C)(C)C)CC[C@H]1C(C)(C)O2 | 3314.9 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Nabilone GC-MS (Non-derivatized) - 70eV, Positive | splash10-0a6s-4059000000-d86f1fa9d2fb7b5aeb43 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Nabilone GC-MS (1 TMS) - 70eV, Positive | splash10-004i-9006500000-fa969e22f9069b4dae8c | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Nabilone GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Nabilone GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nabilone 10V, Positive-QTOF | splash10-00di-0209000000-ae7db58f0d0bea9253a7 | 2016-08-02 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nabilone 20V, Positive-QTOF | splash10-007k-5309000000-fa6f8bf6ae3a68b350a9 | 2016-08-02 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nabilone 40V, Positive-QTOF | splash10-00kf-9142000000-06e05031e6b790e0575a | 2016-08-02 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nabilone 10V, Negative-QTOF | splash10-00di-0009000000-93527ef802493b35cbc6 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nabilone 20V, Negative-QTOF | splash10-00di-0139000000-9dff2b635e80d9a8a438 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nabilone 40V, Negative-QTOF | splash10-0671-4698000000-c6c6c7afb91f8c400cde | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nabilone 10V, Negative-QTOF | splash10-00di-0009000000-e7cb0fa6cccff516dcec | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nabilone 20V, Negative-QTOF | splash10-00di-0009000000-d48b82525261ced239a6 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nabilone 40V, Negative-QTOF | splash10-014i-0039000000-fc9aceb1067cf8a70471 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nabilone 10V, Positive-QTOF | splash10-00di-1009000000-89d93a87d01729ab9bc8 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nabilone 20V, Positive-QTOF | splash10-008i-9216000000-0c92b93a021eea604013 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Nabilone 40V, Positive-QTOF | splash10-0536-9101000000-910f891074aa1437ef37 | 2021-09-24 | Wishart Lab | View Spectrum |
|
---|
General References | - Herman TS, Einhorn LH, Jones SE, Nagy C, Chester AB, Dean JC, Furnas B, Williams SD, Leigh SA, Dorr RT, Moon TE: Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy. N Engl J Med. 1979 Jun 7;300(23):1295-7. [PubMed:375088 ]
- Cunningham D, Bradley CJ, Forrest GJ, Hutcheon AW, Adams L, Sneddon M, Harding M, Kerr DJ, Soukop M, Kaye SB: A randomized trial of oral nabilone and prochlorperazine compared to intravenous metoclopramide and dexamethasone in the treatment of nausea and vomiting induced by chemotherapy regimens containing cisplatin or cisplatin analogues. Eur J Cancer Clin Oncol. 1988 Apr;24(4):685-9. [PubMed:2838294 ]
- Niiranen A, Mattson K: Antiemetic efficacy of nabilone and dexamethasone: a randomized study of patients with lung cancer receiving chemotherapy. Am J Clin Oncol. 1987 Aug;10(4):325-9. [PubMed:3039831 ]
- Einhorn LH, Nagy C, Furnas B, Williams SD: Nabilone: an effective antiemetic in patients receiving cancer chemotherapy. J Clin Pharmacol. 1981 Aug-Sep;21(8-9 Suppl):64S-69S. [PubMed:6271844 ]
|
---|